MANTOVANI, LORENZO GIOVANNI
MANTOVANI, LORENZO GIOVANNI
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
A proposal for Italian Guidelines in pharmacoeconomics
1995 Garattini, L; Grilli, R; Scopelliti, D; Mantovani, LORENZO GIOVANNI
Guidelines for economic evaluations in Italy: recommendations from the italian group of pharmacoeconomic studies
2001 Capri, S; Ceci, A; Terranova, L; Merlo, F; Mantovani, LORENZO GIOVANNI
Adherence to antihypertensive medications and cardiovascular morbidity among newly-diagnosed hypertensive patients
2009 Mazzaglia, G.; Ambrosioni, E.; Alacqua, M.; Filippi, A.; Sessa, E.; Immordino, V.; Borghi, C.; Brignoli, O.; Caputi, A. P.; Cricelli, C.; Mantovani, LORENZO GIOVANNI
Can Europe afford not to implement evidence-based medicine in heart failure?
1998 Szucs, Td; Belisari, A; Mantovani, LORENZO GIOVANNI
Malattia di Alzheimer in Italia: impatto sociale, sanitario ed economico. Farmacoeconomia
1999 Mantovani, LORENZO GIOVANNI; Belisari, A.
Is preventive medical care worth the cost?
1997 Szucs, Td; Belisari, A; Mantovani, LORENZO GIOVANNI
Do different physicians' panels reach similar conclusions? A case study on practice guidelines for limited surgery in breast cancer
1997 A, ; Grilli, R; Filardo, G; Mainini, F; Zola, P; Mantovani, LORENZO GIOVANNI; Liberati, A.
Valutazione farmacoeconomica dell’uso di tramadolo vs ketorolac nella gestione del dolore postoperatorio
2003 Mantovani, LORENZO GIOVANNI
Valutazione economica dello studio AVERT
2007 DE PORTU, S.; Cammarota, S.; Menditto, Enrica; Mantovani, LORENZO GIOVANNI
Good economic practices per gli studi di farmacoeconomia
1994 Garattini, L; Grilli, R; Mantovani, LORENZO GIOVANNI; Scopelliti, D.
New pharmacoeconomic option in uremic anemia management
2007 V., Savica; Mantovani, LORENZO GIOVANNI; D., Santoro; B., Ricciardi; G., Bellinghieri
Is preventive medical care worth the cost?
1997 T. D., Szucs; A., Belisari; Mantovani, LORENZO GIOVANNI
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors
2006 L., Scalone; Mantovani, LORENZO GIOVANNI; P. M., Mannucci; A., Gringeri
Evaluation of scientific research concerning health in the less favored regions of the European Union: health care in three southern Member States (Spain, Greece and Italy)
1995 ABEL SMITH, B; Mossialos, E; Lobo, F; Fattore, G; Mantovani, LORENZO GIOVANNI
Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysis.
2013 Corso, A; Mangiacavalli, S; Cocito, F; Pascutto, C; Ferretti, Vv; Pompa, A; Ciampichini, R; Pochintesta, L; Mantovani, LORENZO GIOVANNI
Cost-Effectiveness Analysis of New Drugs for Chronic Hepatitis C: The Importance of Updating Utility Values.
2014 Cortesi, Pa; Scalone, L; Mantovani, LORENZO GIOVANNI
Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association.
2013 Boriani, G; Maniadakis, N; Auricchio, Alberto; M?ller Riemenschneider, F; Fattore, G; Leyva, F; Mantovani, LORENZO GIOVANNI; Siebert, M; Willich, Sn; Vardas, P; Kirchhof, P.
KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting.
2014 Barone, C; Pinto, C; Normanno, N; Capussotti, L; Cognetti, F; Falcone, A; Mantovani, LORENZO GIOVANNI
Italian population-based values of EQ-5D health states.
2013 Scalone, L; Cortesi, Pa; Ciampichini, R; Belisari, A; D'Angiolella, Ls; Cesana, G; Mantovani, LORENZO GIOVANNI
Healthcare costs associated with hepatocellular carcinoma and the value of care.
2013 Mantovani, LORENZO GIOVANNI; Strazzabosco, M.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| A proposal for Italian Guidelines in pharmacoeconomics | 1.1 Articolo in rivista | 1995 | Garattini, L; Grilli, R; Scopelliti, D; Mantovani, LORENZO GIOVANNI | |
| Guidelines for economic evaluations in Italy: recommendations from the italian group of pharmacoeconomic studies | 1.1 Articolo in rivista | 2001 | Capri, S; Ceci, A; Terranova, L; Merlo, F; Mantovani, LORENZO GIOVANNI | |
| Adherence to antihypertensive medications and cardiovascular morbidity among newly-diagnosed hypertensive patients | 1.1 Articolo in rivista | 2009 | Mazzaglia, G.; Ambrosioni, E.; Alacqua, M.; Filippi, A.; Sessa, E.; Immordino, V.; Borghi, C.; Brignoli, O.; Caputi, A. P.; Cricelli, C.; Mantovani, LORENZO GIOVANNI | |
| Can Europe afford not to implement evidence-based medicine in heart failure? | 1.1 Articolo in rivista | 1998 | Szucs, Td; Belisari, A; Mantovani, LORENZO GIOVANNI | |
| Malattia di Alzheimer in Italia: impatto sociale, sanitario ed economico. Farmacoeconomia | 1.1 Articolo in rivista | 1999 | Mantovani, LORENZO GIOVANNI; Belisari, A. | |
| Is preventive medical care worth the cost? | 1.1 Articolo in rivista | 1997 | Szucs, Td; Belisari, A; Mantovani, LORENZO GIOVANNI | |
| Do different physicians' panels reach similar conclusions? A case study on practice guidelines for limited surgery in breast cancer | 1.1 Articolo in rivista | 1997 | A, ; Grilli, R; Filardo, G; Mainini, F; Zola, P; Mantovani, LORENZO GIOVANNI; Liberati, A. | |
| Valutazione farmacoeconomica dell’uso di tramadolo vs ketorolac nella gestione del dolore postoperatorio | 1.1 Articolo in rivista | 2003 | Mantovani, LORENZO GIOVANNI | |
| Valutazione economica dello studio AVERT | 1.1 Articolo in rivista | 2007 | DE PORTU, S.; Cammarota, S.; Menditto, Enrica; Mantovani, LORENZO GIOVANNI | |
| Good economic practices per gli studi di farmacoeconomia | 2.1 Contributo in volume (Capitolo o Saggio) | 1994 | Garattini, L; Grilli, R; Mantovani, LORENZO GIOVANNI; Scopelliti, D. | |
| New pharmacoeconomic option in uremic anemia management | 1.1 Articolo in rivista | 2007 | V., Savica; Mantovani, LORENZO GIOVANNI; D., Santoro; B., Ricciardi; G., Bellinghieri | |
| Is preventive medical care worth the cost? | 1.1 Articolo in rivista | 1997 | T. D., Szucs; A., Belisari; Mantovani, LORENZO GIOVANNI | |
| Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors | 1.1 Articolo in rivista | 2006 | L., Scalone; Mantovani, LORENZO GIOVANNI; P. M., Mannucci; A., Gringeri | |
| Evaluation of scientific research concerning health in the less favored regions of the European Union: health care in three southern Member States (Spain, Greece and Italy) | 3.1 Monografia o trattato scientifico | 1995 | ABEL SMITH, B; Mossialos, E; Lobo, F; Fattore, G; Mantovani, LORENZO GIOVANNI | |
| Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysis. | 1.1 Articolo in rivista | 2013 | Corso, A; Mangiacavalli, S; Cocito, F; Pascutto, C; Ferretti, Vv; Pompa, A; Ciampichini, R; Pochintesta, L; Mantovani, LORENZO GIOVANNI | |
| Cost-Effectiveness Analysis of New Drugs for Chronic Hepatitis C: The Importance of Updating Utility Values. | 1.1 Articolo in rivista | 2014 | Cortesi, Pa; Scalone, L; Mantovani, LORENZO GIOVANNI | |
| Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. | 1.1 Articolo in rivista | 2013 | Boriani, G; Maniadakis, N; Auricchio, Alberto; M?ller Riemenschneider, F; Fattore, G; Leyva, F; Mantovani, LORENZO GIOVANNI; Siebert, M; Willich, Sn; Vardas, P; Kirchhof, P. | |
| KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting. | 1.1 Articolo in rivista | 2014 | Barone, C; Pinto, C; Normanno, N; Capussotti, L; Cognetti, F; Falcone, A; Mantovani, LORENZO GIOVANNI | |
| Italian population-based values of EQ-5D health states. | 1.1 Articolo in rivista | 2013 | Scalone, L; Cortesi, Pa; Ciampichini, R; Belisari, A; D'Angiolella, Ls; Cesana, G; Mantovani, LORENZO GIOVANNI | |
| Healthcare costs associated with hepatocellular carcinoma and the value of care. | 1.1 Articolo in rivista | 2013 | Mantovani, LORENZO GIOVANNI; Strazzabosco, M. |